期刊文献+

非小细胞肺癌中表皮生长因子受体基因突变的筛查 被引量:3

Detection of genetic mutation of epidermal growth factor receptor in non-small cell lung cancer
下载PDF
导出
摘要 目的检测非小细胞肺癌患者的表皮生长因子受体(EGFR)基因外显子的突变情况。方法收集24例肺腺癌和25例肺鳞癌手术标本,抽提组织DNA,对EGFR基因的1-28号外显子进行扩增并测序,筛查EGFR基因的突变。结果在8例肺腺癌患者中检出EGFR突变,在肺鳞癌患者中未检测到突变。检测到的突变位点位于19-21号外显子内,且均为非吸烟患者,占非吸烟肺腺癌患者的61.5%(8/13)。结论 EGFR基因突变在非吸烟的肺腺癌患者具有较高的发生率,突变主要集中发生于19-21号外显子。 Objective To detect the mutation condition of epidermal growth factor receptor(EGFR) in non-small cell lung cancer(NSCLC) patients.Methods Twenty-four adenocarcinoma(AC) of lung samples and twenty-five squamous cell carcinoma(SCC) samples were enrolled.DNA was extracted,and then the 1-28 exons of EGFR were amplified and sequenced to screen mutations.Results EGFR mutations were detected in eight patients with AC,however,there were no mutations in SCC patients.The mutations were all located within exons 19-21.All the patients who had EGFR mutations were non-smokers accounting 61.5%(8/13)of non-smoking AC patients.Conclusion EGFR activating mutations have high incidence rate in non-smoking AC patients.The EGFR mutations mainly locate within exons 19-21.
出处 《新乡医学院学报》 CAS 2011年第2期190-192,共3页 Journal of Xinxiang Medical University
关键词 非小细胞肺癌 表皮生长因子受体 基因突变 non-small cell lung cancer; epidermal growth factor receptor; genetic mutation
  • 相关文献

参考文献4

二级参考文献25

共引文献42

同被引文献36

  • 1张惠蓉,曹景泰,刘宁朴,贺师鹏.视网膜增殖性疾病玻璃体中表皮生长因子的放射受体定量测定[J].中华眼底病杂志,1996,12(2):91-93. 被引量:12
  • 2李林,李斌,杨安怀,赵婷秀,邢怡桥.人视网膜下膜中ICAM-1及MMP-2的免疫组织化学研究[J].眼科新进展,2005,25(6):519-521. 被引量:3
  • 3Cai Q, Gao Y T, Chow W H, et al. Prospective study of uri- nary prostaglandin E2 metabolite and colorectal cancer risk[J ]. J Clin Oncol, 2006, 24(31): 5010.
  • 4Lanza- Jacoby S, Burd R, Rosato F E Jr, et al. Effect of si- multaneous inhibition of epidermal growth factor recepror and cyclooxygenase 2 in HER - 2/neu positive breast cancer [J]. Clin Cancer Res, 2006, 12(20 pt 1): 6161.
  • 5Brabender J, Park J, Metzger R, et al. Prognostic significence of cyclooxygenase 2 mRNA expression in non - small cell lung cancer[J]. Ann Surg, 2002, 235(3) : 440.
  • 6Esteban J, Robert D, Costanzo A, et al. Lung cancer and cy- clooxygenase- 2[J]. Ann Thorac Surg, 2003, 76(4) : 1327.
  • 7Krysan K, Reckamp K L, Sharma S, et al. The potential and rational for C)X-2 inhibitors in Lung cancer[J]. Anticancer Agents Med Chert, 2006, 6(3) : 209.
  • 8Mascanx C, Mantin B, Paesmans M, et al. Has CA3X - 2 a prognostic role in non - small cell lung cancer A systematic re- view of the literature with meta - analysis of the survival re- sults[J]. BrJ Cancer, 2006, 95(2): 139.
  • 9Yano S, Kondo K, Yamaguchi M, Richmond G, Hutchison M, Wakeling A, et al. Distribution and function of EGFR in human tissue and the effect of EGFR tyrosine kinase inhibition[ J]. An- ticancer Res ,2003,23 (5) :3639-3650.
  • 10Lewis TS, Shapiro PS ,Ahn NG. Signal transduction through MAP kinase cascades[ J]. Adv Cancer Res,1998,74( 1 ) :49-139.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部